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 Populations of GABAergic interneurons in the prefrontal cortex have been implicated in 
control and coordination of complex behaviors such as motivation and decision-making. Although 
the functions of each of the main GABAergic subtypes, SST, PV, and VIP, have been extensively  
investigated  independently, a lack of techniques allowing simultaneous recording has precluded 
the ability to characterize the interactions between these cell types. Staining for markers of GABA 
cell types in thick tissue, and relating identities back to in vivo recordings, will allow explicit and 
direct characterization of how activity covaries in these populations. However, there has been 
minimal success when staining for GABAergic subtypes in thick tissue.  I interrogated the different 
factors that might be affecting successful thick tissue staining using the Cuboid Method which 
enables controlled and efficient thick tissue preparation, staining, and experimental testing. 
Fixation, with both paraformaldehyde and glutaraldehyde, was observed to be a major factor 
influencing the ability of different SST, PV, and VIP antibodies to label their epitopes in thick 
tissue. Additionally, fixation appeared to affect SST and VIP staining differently than PV staining. 
SDS treatment prior to staining was shown to be compatible with GABAergic subtype staining 
while SDS treatment after staining was shown to dramatically decrease staining signal. Like 
others’ findings, blocking was shown to be unnecessary for better PV and SST staining. Lastly, 
relative proportions of SST, PV, and VIP in the PFC and their staining patterns in thick tissue 
matched results from previous work in thin tissue to support that staining was successful and also 
accurate. This research provides the knowledge necessary to successfully stain for SST, PV, and 
VIP in thick tissue in addition to showing the efficacy of the Cuboid Method for testing factors 
affecting staining in thick tissue.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
The prefrontal cortex (PFC) coordinates highly complex behaviors such as decision-making, 
planning, and motivation1,2. In order to coordinate such complex tasks, the PFC has a wide variety 
of outputs including the amygdala3, the ventral tegmental area, the dorsal raphe nucleus, and the 
lateral habenula4. The PFC circuits and their many outputs are implicated in emotional processing, 
reward valuation, addiction, and even depression, emphasizing the importance of further 
exploration of the PFC network2. The importance of understanding more about the PFC and the 
cell types that make up the many inhibitory circuits within it inspired this study which explores an 
optimized method to immunohistochemically probe for specific GABA neurons in thick tissue 
sections of the mouse PFC. The method I have optimized allows for identification of GABA 
neurons that were active during performance of sensory stimulation tasks.  
 
Recent studies have shown that GABA interneurons in the PFC play an integral role in 
coordinating goal-directed behavior through both microcircuits and projection tracts to 
downstream structures5. There are three major categories of GABA interneuron subtypes in the 
PFC; these differentially express either the neuropeptide Somatostatin (SST), the calcium binding 
protein Parvalbumin (PV), or the neuropeptide Vasoactive Intestinal Peptide (VIP)5–7. While PV 
mainly functions in the cytosol to regulate calcium concentrations8 both SST and VIP have 
neuromodulatory effects on postsynaptic neurons. SST has been shown to modulate the voltage 
dependent potassium current in postsynaptic neurons9 whereas VIP has been shown to increase 
cAMP levels in downstream neurons10.  Previous research has elucidated the different functions 
of these molecularly distinct subtypes defined  by expression of SST, PV, and VIP. Using a go/no-
go sensory stimulations task, mice were trained to lick for water based on a sensory stimulus5. 
Individual recordings of neural activity in SST, PV, and VIP interneurons showed correlations to 
distinct behaviors. The SST interneurons were shown to have the highest Ca2+ activity at the onset 
and ending of licking thus indicating that these neurons are implicated in motor-related activity5. 
The PV interneurons were found to have high Ca2+ activity at the onset and ending of licking, in 
response to rewarding trial outcomes, and in response to an auditory stimulus thus this 
subpopulation is implicated in a broad range of task related events5. The VIP interneurons were 
shown to have high Ca2+ activity in response to both rewarding and punishing task outcomes and 
thus were determined to be specialized to respond to task outcomes5. While the aforementioned 
study was limited to individual recordings, the tools optimized in my study will allow for 
simultaneous recordings of multiple GABA subtypes, whose activity can be correlated to behavior 
in unison.  
 
It will be difficult to understand how the brain works if research is focused on individual 
populations of cells, single projections, or isolated brain areas without simultaneously considering 
the many other interconnected structures that are integral to brain function. The brain is a complex 
network with billions of connections between cells. There has been a recent increase in research 
on neural activity at the circuit or system level as the importance of neural connections is realized. 
For example, O’Hare et al.11 showed that studying two striatal circuits simultaneously was more 
powerful at explaining behavior than studying a single circuit in isolation. They recorded indirect 
and direct striatal projection neurons from the dorsolateral striatum and found that habitual 
behavior correlated with Ca2+ activity (indicating neural activity) when both indirect and direct 
circuits were recorded simultaneously but not when they were recorded individually11. The 
function of the GABA interneurons in the PFC can be better understood through simultaneously 
recording all three GABA subtypes and correlating their activity to behavior in a sensory 
stimulation task. Before in vivo imaging and behavioral studies recording from multiple cellular 
populations can be undertaken, the challenge of labelling three different types of GABA neurons 
in thick tissue must be tackled. 
 
Immunohistochemistry is a common way to identify the molecular characteristics of neurons and 
will be used in this study to identify GABA neuron subtypes. To date, very little research has 
focused on staining for GABA interneuron subtypes in thick tissue. Allen et al.12 successfully 
stained for both PV and SST in 100µm thick sections, while Tomer et al.13 stained for both PV and 
SST in 1mm thick tissue. In this study, I stained for the three major GABA subtypes, SST, PV, 
and VIP, in 2mm thick tissue. I hypothesize that optimized immunohistochemistry techniques in 
cleared thick tissue to probe for the three major GABA interneuron subtypes simultaneously will 
allow for identification of neurons after they have been endoscopically imaged. In this way, the 
activity of neurons that are imaged while the mouse was alive can be molecularly characterized 
after death. Thick tissue would be preferred to thin sections for this experiment since it can best 
capture all recorded neurons and increase ease of alignment after staining. The thin section 
technique would make it more difficult to discern the location of endoscopically imaged cells since 
the lens has a large working distance (about 250µm) compared to the width of a thin tissue 
section14. Large volume data sets can provide more information about alignment of cell 
populations and allow for easier visualization of projections and tracts15. Despite the increased 
ability to capture and align cells, there are many difficulties that exist when working with thick 
tissue compared to thin tissue.  
 
Thick tissue has two main limitations in the scope of this study: optical transparency and antibody 
penetration. To tackle the first limitation, I used a combination of lipid removal and immersion in 
refractive index matching solution. Lipid removal, also known as tissue clearing, is a process that 
removes lipids that impair the path of light through the tissue15,16. The process of clearing enables 
large volume samples to be more transparent deep in the tissue16. Some techniques that have been 
developed to clear tissue include CLARITY, iDISCO, CUBIC, ClearT, and FRUIT16. I used a 
clearing method adapted from Chung and Deisseroth’s15 technique called CLARITY, in which 
sodium dodecyl sulfate (SDS) is the main reagent that removes lipids. Refractive index matching 
solution is another integral component of achieving optical transparency as it prevents refraction 
and excess light scattering within the tissue16. Iodixanol, the refractive index matching solution 
used in this study, has been shown to produce high quality deep imaging in uncleared thick tissue17. 
Chung and Deisseroth15 have shown the power of the CLARITY technique to allow for both deep 
imaging and immunohistochemical staining since removing lipids makes tissue more penetrable 
to antibodies.  iDISCO is another method18 designed to both clear thick tissue and increase 
antibody staining abilities. However, only certain antibodies are compatible with this technique, 
limiting the number of targets that can be probed for. With a limited number of tested antibodies, 
the second limitation was tackled by optimizing a protocol to stain thick tissue with each of the 
GABA interneuron antibodies: PV, SST, and VIP.  
 
Optimizing a thick tissue staining protocol involves many factors including fixation type and 
duration, clearing reagents, target epitope, antibody choice, duration of stain, and duration of wash. 
Fixation, which is done to maintain tissue structure, often impairs antibody staining by forming 
cross-links that impede immuno-recognition of epitope by the antibody19. In addition, antibody-
fixative interactions vary based on epitope and antibody; thus, these factors must be carefully 
considered when trying to optimize an antibody in thick tissue19. Testing the many variables that 
impact thick tissue staining requires an immense amount of time since diffusion of antibodies and 
wash solution through thick tissue is slow. The larger the distance over which diffusion takes place, 
the longer diffusion takes based on Fick’s Second Law in which diffusion rate is inversely 
proportional to the distance particles must travel20. In addition, the quantity of reagents needed to 
process and label thick tissue is drastically increased due to increased sample volume. To address 
slow diffusion time and large reagent quantities, I developed a technique that allowed for efficient 
immunohistochemical variable testing for many different PV, SST, and VIP antibodies. The 
technique involves small tissue chunks called cuboids. Brains were cut into 2mm thick sections, 
then cut again into eight cuboids. The cuboids enable controlled experimentation through matched 
anatomical pairs from each 2mm brain section. The left cuboid served as the experimental control, 
while the right cuboid was subjected to the experimental variable. Matched samples of cuboids 
from the same brain also allowed many antibodies to be tested in the context of varying reagent 
conditions. This tool is useful for testing antibodies prior to large thick tissue experiments in the 
future.  
 
Through the use of the cuboid technique, six SST, three PV, and two VIP antibodies were tested 
in thick tissue. The efficacy of each antibody was first tested in thin section. Successful antibodies 
were then tested in thick sections using the same reagent conditions as in thin sections. The effects 
of SDS, Glutaraldehyde, and Glycine on antibody staining were tested. Antibody accuracy was 
then tested for one SST and one PV antibody in transgenic SST-cre TdTom and PV-cre TdTom 
mice. Overlap between transgenic expression of interneuron markers and immuno-labelling of 
interneuron markers was observed. The successful thick tissue staining with SST, PV, and VIP 
GABA interneuron subtype antibodies lays the foundation for in vivo calcium imaging in which 
behavior can be correlated to simultaneous GABA interneuron activity in the PFC. 
 
The relationship between relative GABA subtype firing and behavior will be explored through 
endoscopic in vivo calcium imaging of Vgat-Cre GCaMP6 mice while they perform a go/no-go 
sensory stimulation task similar to that performed by Pinto and Dan5. A cube of brain tissue that 
contains the recorded cells will be extracted from the brain and stained with PV, SST, and VIP 
antibodies to discern which GABA neurons correspond to which subtypes. The calcium imaging 
data can then be aligned with the cell staining results using an image alignment program. 
Interneuron activity can then be related to behavior within one mouse to understand how patterns 
of GABA interneuron firing predict observed behavioral outputs.  
 
Materials and Methods 
Transgenic mice and handling.  
Transgenic mice were maintained and bred at Cornell following accepted IACUC policies. 
A total of 4 C57B6J, 3 SST-TdTomato-Cre Thy1-YFP mice, and 4 PV-TdTomato-Cre Thy1-YFP 
mice were used in the following experiments. SST-TdTomato-Cre Thy1-YFP mice and PV-
TdTomato-Cre Thy1-YFP mouse lines were created at Cornell from Jackson Laboratories 
transgenic SST-Cre and PV-Cre lines. Mice were housed in groups and maintained on a 12hr/12hr 
light-dark cycle. 
 
 
Perfusion.  
8-week-old mice were anesthetized with pentobarbital at a dose of 65mg/kg. Once deeply 
anesthetized, the mice were placed on the perfusion platform in the fume hood. An incision was 
made in the abdomen with dissection scissors to expose the peritoneal cavity. Incisions were 
extended up both the right and left sides of the abdomen and thoracic cavity to expose the heart. 
A small incision was made in the right atrium and a 25 gauge needle was then inserted into the left 
ventricle. The circulatory system was perfused at a rate of 5mL/min with 20mL of 0.5% Heparin 
Nitrite in PBS. The circulatory system was then perfused with 20mL of 4% paraformaldehyde in 
PBS at 5mL/min. Brains were dissected and drop fixed overnight in 4% paraformaldehyde at 4°C. 
Brains were then dehydrated for cryoprotection in 30% sucrose at 4°C for 18 hours. 
 
Thin tissue preparation and immunohistochemistry. 
 Fixed and dehydrated brains were then placed on the microtome, frozen with dry ice, and 
sliced into 50µm coronal sections. Three sections that included the prefrontal cortex (one rostral, 
one medial, and one caudal) were placed in a 40mL glass vial and washed with PBST. This was 
repeated to prepare one vial for each antibody. Sections were blocked for one hour at room 
temperature in 10% Normal Donkey Serum (NDS) in PBST or 10% Normal Goat Serum (NGS) 
in PBST to match the secondary antibody. After blocking, primary antibodies (Chicken anti-SST 
3:1000, SYSY; Rat anti-SST 3:1000, Millipore; Mouse anti-SST (H-11) 3:1000, Santa Cruz 
Biotechnology Inc.; Rat anti-SST (YC7) 3:1000, Santa Cruz Biotechnology Inc.; Mouse anti-SST 
(D-12) 3:1000, Santa Cruz Biotechnology Inc.; Mouse anti-VIP (H-6) 3:1000, Santa Cruz 
Biotechnology Inc.; Mouse anti-SST (G-10) 3:1000, Santa Cruz Biotechnology Inc.) were diluted 
in 5% Normal Donkey Serum in PBST or 5% Normal Goat Serum in PBST and the sections were 
incubated overnight at room temperature. Sections were then washed in PBST at room temperature 
for 1, 5, and 10 minutes. The secondary antibodies (Donkey anti-Rat Alexa Fluor 647 3:400, 
Invitrogen; Goat anti-Mouse IgG1 Fluor 647 3:400, Invitrogen; Goat anti-Mouse IgG2a Fluor 647 
3:400, Invitrogen; Goat anti-Mouse IgG2b Alexa Fluor 647 3:400, Invitrogen; Goat anti-Chicken 
IgY Alexa Fluor 647 3:400, Invitrogen) were diluted in 5% NDS or 5%NGS and left to incubate 
overnight at room temperature. Primary omissions were prepared the same way but without 
incubation in primary antibody. Successful observed labelling was not due to non-specific 
secondary antibody interactions since primary omission results showed lack of specific staining. 
Sections were then washed in PBST at room temperature for 1, 5, 10, and 60 minutes. Sections 
were then incubated in a 1:1000 dilution of DAPI and then washed in PBS at room temperature 
for 1, 5, and 10 minutes. Sections were then mounted in 90% glycerol and sealed with clear nail 
polish for confocal imaging.  
 
Thin section imaging. 
 A Zeiss Laser Scanning Microscope 800 was used for imaging. The 10x water objective 
was used to visualize staining. The 647nm laser was used to image all samples with a gain of 520V, 
laser power of 2.5%, and pinhole of 100um. A single tile (765x765 pixel section) from the top of 
each cortex was imaged with the 25x water objective to observe antibody staining. Antibody 
staining efficacy was determined by comparing staining patterns to In Situ Hybridization images 
from the Allen Brain Atlas21.  
 
Thick tissue preparation- “The Cuboid Method”.  
Fixed and dehydrated brains were placed in a coronal matrix and cut into 2mm thick 
sections. Sections were then placed in a petri dish and cut into eight roughly 2mmx2mm pieces, 
referred to as “cuboids”. The cuboid method is depicted in the figure below. Cuboids are cut in 
this way to allow for right/left anatomical comparisons within one section of one brain. 
 
Figure 1 |  “The Cuboid Method” – The above image depicts the process of cutting each brain into 
sections in the matrix and then cutting each section into further halves or eighths (cuboids) that are 
paired and subjected to different reagent conditions before mounting in a gasket and imaging. 
 
Basic thick tissue fixation and immunohistochemistry.  
Brains are cut into 2mm sections in a coronal matrix 
Halves or eighths (cuboids) are cut, treated, and mounted 
Brains sections are placed on a grid to be cut  
Cuboids were placed in labelled 5mL tubes and fixed in 0.01% Glutaraldehyde at 4°C 
overnight. The cuboids were washed three times for five minutes in PBST and then quenched with 
0.5mol/L Glycine overnight at 4°C to stop further glutaraldehyde cross-linking reactions. Cuboids 
were then washed three times for five minutes in PBST and cleared in 6% sodium dodecyl sulfate 
(SDS) for five days at 37°C. Cuboids were then washed for 2 days in PBST. Primary antibody 
(Chicken anti-SST 1:200, SYSY; Rat anti-SST 1:200, Millipore; Mouse anti-SST (H-11) 3:400, 
Santa Cruz Biotechnology Inc.; Rat anti-SST (YC7) 3:400, Santa Cruz Biotechnology Inc.; Mouse 
anti-SST (D-12) 3:400, Santa Cruz Biotechnology Inc.; Mouse anti-VIP (H-6) 3:400, Santa Cruz 
Biotechnology Inc.; Mouse anti-SST (G-10) 3:400, Santa Cruz Biotechnology Inc.; Goat anti-
Parvalbumin 1:200, Abcam; Rabbit anti-Parvalbumin 1:200, GenScript; Rabbit anti-VIP 1:200, 
ImmunoStar) was then diluted in PBST, added to the cuboids and incubated for three days at 37°C. 
Primary antibody was then removed and cuboids were washed 3 times for three minutes and then 
left to wash for two days in PBST. Secondary antibody (Donkey anti-Rat Alexa Fluor 647 3:250, 
Invitrogen; Goat anti-Mouse IgG1 Fluor 647 3:250, Invitrogen; Goat anti-Mouse IgG2a Fluor 647 
3:250, Invitrogen; Goat anti-Mouse IgG2b Alexa Fluor 647 3:250, Invitrogen; Goat anti-Chicken 
IgY Alexa Fluor 647 1:100, Invitrogen, Donkey anti-Rabbit Alexa Fluor 647 1:100, Invitrogen) 
was then diluted in PBST and added to cuboids to incubate for three days at 37°C. Secondary 
antibody was then removed and cuboids were washed three times for three minutes and then left 
to wash for two days in PBST. Primary omissions were also prepared in which the same steps as 
described were completed except for addition of primary antibody. Successful observed labelling 
was not due to non-specific secondary antibody interactions since primary omission results showed 
lack of specific staining Pieces were then placed in Iodixanol for refractive index matching and 
then mounted in Iodixanol in 2mm thick gaskets.  
  
 
Variation to thick tissue preparation.  
The above protocol was modified in several experiments to test effects of variables that 
differ between thick tissue and thin tissue staining. Glutaraldehyde (GA), Glycine, SDS, and 
blocking were omitted individually in different experiments, keeping the rest of the protocol 
constant. 
 
Microscopy.  
A ZEISS Confocal Laser Scanning Microscope 800 was used for imaging. The 10x water 
objective was used to image the cuboids. The 647nm laser was used to image PV staining in 
Glutaraldehyde and SDS treated tissue with a gain of 500v, laser of 0.5%, and pinhole of 76um. 
The 647nm laser was used to image SST staining in non-GA and non-SDS treated tissue with a 
gain of 520v, laser of 1.5%, and pinhole of 100um. Single tiles from the cortex were compared 
across samples for presence of antibody staining and Z-stacks were obtained to determine depth 
of antibody staining and effects of different reagents. 
 
Image Display.  
Experimental groups were imaged with the same laser, gain, and pinhole settings. Gamma 
was adjusted to the same value in all images to enable fair comparison of cell body brightness to 
background signal across samples. Z-stacks were made into orthogonal projections using Zen 
Image Processing Software.  
  
 
Data Analysis. 
ImageJ was used to count cells and Imaris was used to quantify the intensity of stained 
cells. Cells were counted in ImageJ by changing the image to greyscale (8bit), the adjusting the 
threshold to 1-2%, and analyzing particles that are 0.001-infinity inch2, circularity 0.00-1.0. Cells 
in Imaris were chosen based on size, quality, and distance from the surface. Cell diameter across 
the x-y axis was chosen to have a 10µm minimum while diameter in the Z direction was chosen to 
have an 18µm minimum due to image distortion from confocal imaging. Background subtraction 
was used to smooth the surface and make it easier to determine foreground cells from background. 
Imaris data was processed by a custom program in MATLAB written by Dave Bulkin to determine 
foreground intensity, background intensity, and overall intensity for each Z layer. Results were 
then graphed in Excel. 
 
Results 
Testing SST, PV, and VIP antibody efficacy 
To molecularly characterize GABA interneurons in thick tissue, antibodies targeted to three 
GABA interneuron subtypes, SST, PV, and VIP, were tested in thick tissue. Antibodies were 
selected based on successful results in thin tissue from a variety of sources5,22,23. Initially, SST, 
PV, and VIP antibodies were tested in 2mm thick tissue that was fixed for five days in 4%PFA 
with subsequent fixation in GA for 24 hours. Strong fixations are commonly used in thick tissue 
preparation to maintain tissue structure and integrity during clearing15,17,24, thus thick tissue 
prepared in a typical manner was used for initial antibody testing in thick tissue. All SST antibodies 
(Mouse anti-SST (H-11), Mouse anti-SST (D-12), Rat anti-SST (YC7), Mouse anti-SST (G-10), 
Millipore Mouse anti-SST, and Chicken anti-SST) and one VIP antibody (Mouse anti-VIP (H-6)) 
failed to stain neurons specifically in thick tissue. Both PV antibodies (Goat anti-PV and Rabbit 
anti-PV) and one of the VIP antibodies (Rabbit anti-VIP) did show specific labelling of neurons 
in thick tissue. Antibodies that failed to stain were tested further in an attempt to optimize them 
for thick tissue staining. 
 
Thin tissue staining was conducted to determine whether the lack of staining with the six SST 
antibodies and one VIP antibody was due to incompatible thick tissue prep or ineffectiveness of 
the antibody itself. Results from staining 50µm thin tissue with each of the previously unsuccessful 
antibodies showed that Mouse anti-SST (H-11), Mouse anti-SST (D-12), and Rat anti-SST (YC7) 
were effective antibodies and worth pursuing in thick tissue (Fig. 1A). The three successful SST 
antibodies visibly stained cells, whereas Mouse anti-SST (G-10), Millipore Mouse anti-SST, 
Chicken anti-SST, and Mouse anti-VIP did not stain any cells even when imaged at 40x.  This did 
not appear to be due to excessive background staining as all samples were imaged with the same 
gain and laser and failed samples did not appear brighter than successfully stained samples. Thus 
the lack of staining is attributed to failure of antibody to bind antigen, not excessive background. 
To count cells, single anatomically matched tiles from the cortex as shown in Fig. 1A were imaged 
with the same laser and gain to allow for fair comparisons between antibodies. Cells were detected 
and counted in ImageJ (Fig. 1B). The anti-SST (H-11) antibody stained the most cells, Rat anti-
SST (YC7) stained the second largest number of cells, and Mouse anti-SST (D-12) stained the 
least number of cells (Fig. 1B). The successful thin tissue staining with the three SST antibodies 
that had previously failed in thick tissue indicated that a component of the thick tissue preparation 
might be impacting epitope recognition.  
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Figure 2 -Thin tissue staining proves efficacy of three SST antibodies | A, Images showing 
SST and VIP antibody staining in thin sections. Staining was observed with Rat a-SST-YC7, Ms 
a-SST-H-11, and Ms a-SST-D-12. White box shown in the upper left image is the tile displayed 
in the upper right image. The white box in the middle of the upper right image depicts the area that 
was imaged at 40x to produce the small image in the corner of the upper right image. B, Bar chart 
showing number of cells counted in ImageJ for each antibody tested in thin section. 
 
Thick tissue optimization for SST antibodies 
Next, I looked at the factors that differ between the thin and thick tissue preparation and 
immunohistochemistry (IHC) in order to figure out what was preventing specific staining in thick 
tissue. In thick tissue preparation, there are multiple steps that differ from thin tissue preparation 
such as fixation with GA, quenching with glycine, delipidation with SDS, lack of blocking, 
refractive index matching in Iodixanol, and generally longer incubation periods and washes (Fig. 
3). Major variables that impact staining such as fixation, blocking, and SDS treatment were tested 
independently to determine what might be preventing staining in thick tissue. To expedite the 
process of testing and to decrease costs of the thick tissue staining process, the cuboid method 
(described above in methods) was used. Using small cuboids of thick tissue minimizes reagent 
volumes as well as time needed for diffusion of both antibodies and wash solution. Despite the 
increased efficiency of this method compared to whole section or whole brain staining, the process 
still takes about 18 days from the moment of brain harvest to imaging the samples (Fig. 3). 
 Figure 3 | Timeline depicting the process of preparing and staining thick tissue cuboids. This 
process was modified throughout experimentation to test effects of different variables on thick 
tissue IHC. 
 
Mouse anti-SST (H-11), Mouse anti-SST (D-12), and Rat anti-SST (YC7), were chosen to test 
factors that affect staining. The timeline depicted in Figure 3 shows the baseline procedure that 
was used to prepare and stain thick tissue. Small variations to the timeline allowed testing of 
different factors affecting thick tissue staining while maintaining within-study control between 
experiments.  
 
Duration of formaldehyde fixation 
I first focused on testing a major factor that differed between thin and thick tissue preparation 
which was duration and type of fixation. The first aspect of fixation that I looked at was duration 
of fixation in 4%PFA. The brains that had been previously used for thick tissue experiments in the 
initial stages of the project had been drop fixed for five days in 4%PFA at 4°C. The SST antibodies 
were successful in thin sections drop fixed for only 24 hours in 4%PFA, so I tried staining thick 
tissue cuboids that had been subject to the following conditions: drop fix for 24 hours in 4%PFA 
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and drop fix plus SDS addition for 3 days. Minimal drop fix proved to be compatible with SST 
antibody staining in thick tissue for all three SST antibodies as did drop fix with SDS treatment 
(Fig. 4).  
 
Figure 4 – SST Staining in lightly fixed, non-SDS treated, thick tissue | 
Immunohistochemical staining of SST neurons in cuboid from the mouse cortex. Upper right 
hand panel shows 25x imaging of stained SST neurons. All cuboids were drop fixed in 4%PFA 
overnight and then stained as per the timeline in Figure 3.  A, Immunohistochemical staining of 
SST neurons with Mouse anti-SST-D-12 antibody. B, Immunohistochemical staining of SST 
neurons with Rat anti-SST-YC7 antibody. C, Immunohistochemical staining of SST neurons 
with Mouse anti-SST-H-11 antibody. 
 
Glutaraldehyde fixation 
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The next fixative tested was GA. GA is a very strong and fast working fixative25 such that the 
maximum duration of GA fixation for thick tissue was 24 hours. Cuboids were drop fixed with 4% 
PFA for 24 hours and then treated with 10ul of 10% GA or drop fixed, treated with SDS and then 
treated with GA. The GA dose that was added was about 2-5x higher than typical protocols15,17 in 
order to determine the impact that GA had on tissue staining. Both fixation experiments resulted 
in no specific neuronal staining with any of the SST antibodies and GA greatly increased surface 
auto-fluorescence compared to non-GA treated cuboids such that imaging with the same laser 
power as non-GA treated tissue led to saturation (Fig 5A). Figure 5A shows two anatomically 
matched cuboids from the same cortical brain slice. The only difference in treatment between the 
two cuboids was that the left was not treated with GA while the right one was treated with GA. 
The striatum and hippocampus are barely discernable in the GA overdosed cuboid compared to 
the non-GA treated cuboid. In addition, it is evident that there is antibody staining in the non-GA 
treated cuboid and no antibody staining detectable in the GA treated cuboid. Figures 5B and 5C 
show the impacts GA can have on auto-fluorescence over depth. Images B and C were taken with 
the same laser power and gain and are depicted in range indicator, a LUT that makes the lowest 
signal black and the highest signal white, such that saturated fluorescence is white and no signal 
is black. It is evident that the GA treated cuboid has much higher fluorescence throughout the 
tissue in comparison to the non-GA treated cuboid. GA created very high auto-fluorescence on the 
surface of the tissue, indicated by the peak in the graph in Figure 5E. Both Figure 5D and 5E show 
that auto-fluorescence drops off significantly further into the tissue but never reaches signal levels 
as low as non-GA treated tissue. The drop off in auto-fluorescence intensity is much more evident 
throughout tissue depth in the GA treated chunk than in the non-GA treated chunk. 
 Figure 5 – Effects of glutaraldehyde on tissue staining and fluorescence| A, Left image is a 
cuboid dropped fixed for 24hr in 4%PFA and not treated with GA. Right image is an anatomically 
matched cuboid from the same brain section that was dropped fixed for 24hr in 4%PFA and treated 
with 10ul of 10% GA. Identical imaging settings were used when imaging the two cuboids. B, 
Large image is a maximum intensity projection of a single tile from non-GA treated cuboid in 5A 
displayed in range indicator. Smaller images are single plan Z-stacks depicting the change in 
fluorescence moving deeper into the tissue. C, Large image is a maximum intensity projection of 
a single tile from the GA treated cuboid in 5A displayed in range indicator. Smaller images are 
single plane Z-stacks depicting the change in fluorescence moving deeper into the tissue. D, Bar 
chart showing average signal intensity throughout depth in the non-GA and GA treated cuboids 
from 5A.  Average signal intensity was calculated from single Z-stacks at the surface, in the 
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middle, and deep into the cuboids. E, Line graph showing the change in average signal intensity 
over depth for the non-GA and GA treated cuboids in 5A. 
 
Effects of GA on SST vs PV immunohistochemistry 
After seeing that high doses of GA dramatically increased the background when staining for SST, 
I tested the impacts of high doses of GA on PV staining with the Rabbit (Rab) anti-PV antibody. 
The exact same cuboid treated with 10ul of 10% GA that failed to stain with SST H-11 was stained 
with Rab anti-PV successfully. The within cuboid control increases confidence that SST and PV 
antibodies are impacted differently by GA fixation such that PV produces cell staining in over-
fixed tissue, while SST antibodies do not stain over fixed tissue as shown in figure 6 A and B. The 
Z depth images in Figure 6 show that antibody staining with the PV antibody is much more 
effective on the surface than throughout the tissue when over fixed with GA.  
 
Figure 6 – Glutaraldehyde impacts PV and SST staining differently  | A, Upper left image 
depicts GA treated cuboid stained with Mouse anti-SST-H-11. Upper right image shows a 
maximum intensity projection of a single tile of cortex. No staining is evident. Lower images are 
single Z layers at the surface, 100µm, 200µm, and 300µm into the tissue. B, Same as in A except 
cuboids were treated with Rab anti-PV and staining was evident. 
 
Effects of post SDS treatment on staining 
SDS treatment is commonly used to clear lipids from tissue to enhance deeper imaging in thick 
tissue26,27, and also to enhance antibody penetration depth. I was interested in observing the effects 
of SDS treatment after immunohistochemical staining with SST. SDS has been shown to denature 
proteins and prevent epitope recognition27, thus making it possibly beneficial to perform IHC prior 
to delipidation to enhance epitope recognition. On the contrary, SDS has also been shown to 
remove antibody staining at both high temperatures17 and low pH28, thus possibly making it 
counter-productive to stain and then delipidate tissue. Not only has SDS been shown to remove 
staining, but also decrease fluorescence by denaturing fluorphores27,28. I wanted to see if SDS 
treatment at a mild pH and 37°C could delipidate cuboids without removing antibody or denaturing 
epitopes and fluorophores. Cuboids treated with only 4%PFA were incubated in primary antibody 
against SST and then compatible secondary antibody. Cuboids were imaged to determine baseline 
staining (Fig 7). Cuboids were then dismounted, washed, and treated with 2% SDS for 2 days at 
37°C. Cuboids were then imaged again to determine the intensity of antibody staining post SDS 
treatment. As shown in Figure 7, antibody staining intensity and background signal both decreased 
for all three antibodies. Mouse anti-SST D-12 showed the most drastic decrease in SST signal, 
with only two cells still visible after SDS treatment (Fig. 7B). The cuboids were then again 
dismounted, washed, and incubated in secondary antibody to determine if the decrease in signal 
after SDS was due to denaturing the fluorophore or if it was due to denaturing or removal of 
primary antibody. I expected that denaturing the fluorophore was responsible for decreased signal 
but surprisingly, adding secondary antibody did not increase antibody specific SST signal (Figure 
7). The background signal appeared to increase but the number of visibly stained cells did not 
increase from post SDS levels. Figure 7B shows that cell number continued to decrease after 
secondary antibody addition. The continued decrease in cell bodies could be due to extra washing 
or too much time spent at 37°C. Images in Figure 7 are all maximum intensity projections that 
range from Z levels at the surface to a Z level of 400µm.  Images are displayed in range indicator 
to show increases and decreases in background and foreground signal intensity.  
 
Figure 7 – Impacts of post-staining SDS treatment | A, Images showing single tile maximum 
intensity projections of cuboids stained with all three successful SST antibodies. Stages of 
experiment are depicted across the top. Leftmost images showing SST staining in 4%PFA treated 
cuboids across all three antibodies. The middle images show staining in the same cuboids after 
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SDS treatment. The rightmost images show the same cuboids after being re-stained with secondary 
antibody. All images are displayed in range indicator to best show changes in signal intensity. B, 
Bar chart showing the change in number of detectable stained cells across all three antibodies. 
‘Pre’ refers to cell bodies detected in normally stained tissue. ‘Post SDS’ refers to cell bodies 
detected after incubating the stained cuboids in SDS. ‘Post Re-stain’ refers to cell bodies detected 
after incubating the SDS treated tissue in secondary antibody. The two Rat anti-SST-YC7 trials 
were averaged to give average number of cells stained at each experimental stage. Decrease in cell 
number is evident across all antibodies. 
 
Effects of blocking in thick tissue 
Next, I tested whether blocking in thick tissue might enhance staining. Blocking is typically used 
in IHC protocols to minimize non-specific antibody binding and decrease high background29,30. 
Blocking was used in the thin tissue experiments in which SST neurons were successfully stained, 
thus I hypothesized that blocking in thick tissue might enhance staining to the level that was 
achieved in thin tissue. One pair of cuboids were drop fixed in 4% PFA, treated with SDS, and 
stained with Rabbit anti-PV, while the other pair was drop fixed, treated with GA, then treated 
with SDS, then stained with Mouse anti-SST H-11. One cuboid from each set was blocked for one 
hour prior to staining in either 10% NDS or 10% NGS (per methods section) depending on 
secondary antibody, while the other cuboid was not blocked. Primary and secondary incubations 
were both done in 5% blocking solution. Background fluorescence appeared to be similar between 
blocked and non-blocked tissue (Fig. 8A). The cuboids stained with Rab anti-PV showed 
significant cell body staining regardless of blocking (Fig. 8A). I expected there to be a much lower 
surface fluorescence for blocked tissue versus non-blocked tissue and that this difference in 
fluorescence would become negligible by the middle of the tissue. There did not appear to be a 
major difference in tissue surface fluorescence intensity between blocked and non-blocked 
samples, in fact the blocked sample appeared to have slightly higher surface fluorescence than the 
non-blocked sample (Fig. 8B). Fluorescence intensity appeared to decrease at a similar rate in both 
cuboids, reaching a similar low level of fluorescence by 250µm into the tissue. In the GA treated 
cuboids stained with Mouse anti-SST H-11, there also did not appear to be a difference in average 
fluorescence intensity between the blocked and non-blocked cuboids (Fig. 8C). Cuboids both 
appeared to have minimal staining due to GA but blocking did not enhance staining since there 
did not appear to be more cell bodies nor better signal for stained cell bodies (Fig. 8C). The line 
graph in Figure 8D shows that in GA treated tissue, blocking does not decrease average 
fluorescence as initially expected. In fact, cuboids have very similar average surface fluorescence 
levels and at about 250µm average fluorescence in both cuboids reaches the same level (Fig. 8D). 

 Figure 8 – Impact of blocking on background staining | A, Large images show effects of not 
blocking versus blocking in cuboids stained with Rab anti-PV. Smaller images show average 
intensity and staining at Z depths of 30µm, 100µm, and 200µm into the tissue. B, Line graph 
showing difference in average fluorescence intensity over depth in Rab anti-PV stained tissue 
between blocked and non-blocked tissue. C, Image showing effects of not blocking versus 
blocking in cuboids stained with Mouse anti-SST H-11 and treated with GA. Smaller images show 
average intensity and staining at Z depths of 30µm, 100µm , and 200µm into the tissue.  D, Line 
graph showing difference in average fluorescence intensity over depth in Mouse anti-SST H-11 
stained tissue between blocked and non-blocked tissue. Cell body counts from each maximum 
intensity projection were determined in ImageJ. 
 Antibody comparisons in thick tissue 
All six successful GABA interneuron antibodies were evaluated based on cell count and average 
signal to noise ratio. Cuboids stained with SST antibodies (D-12, YC7, and H-11) and the Rab 
anti-VIP antibody were treated with 4%PFA overnight at 4°C as this treatment resulted in the best 
staining. Cuboids stained with Goat anti-PV and Rab anti-PV were treated with 4%PFA overnight, 
0.5% GA overnight, and then treated with 6% SDS as these were the conditions initially tested in 
thick tissue that produced good results. Figure 8A shows 10x imaging of single tiles of each cuboid 
made into maximum intensity projections to show cell staining between the surface and 400µm 
deep. Figure 8B shows 25x imaging of successfully stained cells. Both images show the sparsity 
of SST and VIP staining compared to PV staining. Background staining appears to be highest for 
the VIP antibody. The graph in Figure 8C depicts signal to noise ratios for each antibody based on 
all Z stacks in the maximum intensity projections for each cuboid in 8A and 8B. The bar chart 
shows that the PV antibodies had the best signal to noise ratio, determined by dividing the signal 
of the cells by the signal of everything except the cells. The SST H-11 showed to have the best 
signal to noise ratio of the SST antibodies. The VIP antibody appeared to have the lowest signal 
to noise ratio, evident in Figure 8A and B as it is hard to determine cells from background 
fluorescence. From the graph in Fig. 8D it is evident that the PV antibodies stained the most cells, 
SST antibodies stained the second largest number of cells with SST H-11 staining the highest 
number of cells. The VIP antibody appeared to stain the least number of cells.  
 Figure 9 – Successful staining with SST, PV, and VIP antibodies | A, 10x imaging of all GABA 
interneuron antibodies that successfully stained thick tissue. All images are maximum intensity 
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projections of single tiles from PFC cuboids. B, 25x imaging of stained cell bodies from cuboids 
in 9A. C, Bar graph showing signal to background comparison across antibodies. Average signal 
of cell bodies was divided by average signal of everything else except cell bodies across all Z-
depths to calculate ratios for all antibodies. D, Bar chart showing number of cells counted in 
ImageJ for each antibody. Cell counts were obtained from the maximum intensity projections in 
9A, and thus represent a volume of XX x YY x ZZ µm. 
 
Next, the three SST antibodies were further compared to determine differences in signal-noise 
ratios across Z-depths in the tissue. The signal to noise ratios for these antibodies were plotted over 
depth into the tissue to determine which antibody had the best staining deep into the tissue since 
the goal of the experiment is to successfully stain thick tissue with GABA interneuron antibodies. 
It is evident that Mouse anti-SST D-12 has by far the lowest signal to background ratio such that 
signal is only 1.5 times as intense as background fluorescence (Fig. 10). It is interesting that deep 
into the tissue the signal to background ratio improves by about 25% for the Rat anti-SST YC7 
antibody such that deep into the tissue the H-11 and YC7 signal to background ratios reach similar 
levels (Fig 10). The graph shows that in general H-11 appears to have cell body signal that is 2.5 
times the background signal. The YC7 antibody appears to have cell body signal 2 times that of 
the background at the surface. The YC7 signal to noise ratio increases deep into the tissue such 
that at 400µm the signal is about 2.4 times that of the background. The D-12 antibody appears to 
have the lowest cell body fluorescence at 1.5 times that of the background signal. 
 Figure 10 – Differential staining quality between three successful SST antibodies |  A, Images 
showing staining  across each successful SST antibody at Z depths of 100µm, 200µm, and 350µm.  
B, Line graph showing the average signal to background ratio for each of the successful SST 
antibody throughout depth. Average cell body signal intensity from each Z layer in a single tile 
was divided by the average intensity of everything except the cell bodies in each Z layer to 
determine ratios at each depth. 
Comparison of transgenic and IHC labelling of PV and SST neurons 
Once immuno-staining with antibodies against each GABAergic subtype had been achieved, I was 
interested in looking at how similar IHC staining was to transgenic labelling of SST and 
GABAergic subtypes. To determine the accuracy of immunostaining within samples, PV-Cre mice 
expressing TdTom in PV neurons were used to look at the overlap of PV staining with 
transgenically labelled PV neurons and SST-Cre mice expressing TdTom is SST neurons  were 
used to look at the overlap of SST staining with transgenically labelled SST positive neurons. 
Initially, PV-Cre mouse brains were dissected to look at the overlap between transgenic labelling 
of PV neurons and immunohistochemical labelling of PV neurons. Unfortunately, the PV-Cre line 
did not work as expected. TdTom was expressed in almost all neurons, not specifically in PV 
neurons when the expression pattern was compared to In Situ Hybridization (ISH) data of PV RNA 
from the Allen Brain Atlas21. Luckily, the SST-Cre mice had successful TdTom expression in SST 
neurons when compared to ISH data from the Allen Brain Atlas21.  SST-Cre brains were stained 
with both PV and SST antibodies to look at population overlap. The 25x image in Figure 11A 
shows the two distinct PV and SST populations of GABAergic interneurons in the PFC. The Rab 
anti-PV antibody, depicted in cyan, stained a distinct subset of neurons from the SST neurons 
transgenically labelled with TdTom. The difference in staining is indicated by the cyan and 
magenta arrows in Figure 11. This corroborates data showing that these GABAergic subtypes of 
neurons represent distinct populations31–33. Overlap in SST staining and transgenic SST expression 
was observed when SST-Cre brains were stained with Rat anti-SST YC7 antibody (Figure 11B). 
Transgenically labelled SST neurons, shown with magenta cell bodies, express TdTom driven by 
Cre. Magenta neurons appear to have peripheral staining around the cell body due to Rat anti-SST, 
shown in cyan. The 25x image in Figure 11B shows the overlap between transgenic and IHC 
labelled SST neurons in multiple cells. This confirms that the Rat anti-SST YC7 antibody is 
successful since it stained cells that transgenically express SST. 
 
An internal study was also conducted in this experiment to look at the differences in morphology 
and staining of brain sections fixed with 3µl of 10% GA for 24hr versus not fixed with GA. Both 
Figure 11A and Figure 11B show thick brain sections with one side fixed in GA and the other side 
not fixed in GA. Below the full coronal images in both 11A and 11B, maximum intensity 
projections are shown depicting single cortical tiles from the GA fixed side and the non-GA fixed 
side. It appears that overall auto-fluorescence is brighter in the GA fixed sections than the non-GA 
fixed sections, as described above. The PV stained sections have similar staining patterns 
regardless of GA addition. The SST stained section appears have less staining when fixed with 
GA. Since the GA dose in this experiment was more moderate, at 3µl per half 2mm section, 
minimal SST staining was observed whereas cuboids fixed with 10µl of GA did not have any 
staining at all. The tissue appears somewhat more intact in GA treated sides since strong fixatives 
like GA are meant to preserve tissue structure.  
 Figure 11 – Comparison of transgenic labelling with PV and SST staining in SST-Cre mice | 
A, Upper image is 2mm rostral section of transgenic SST-Cre-TdTom mouse brain stained with 
Rab anti-PV. TdTom expressing SST neurons are depicted in magenta while 
immunohistochemically labelled PV neurons are depicted in cyan. The left side of the Rab anti-
PV stained brain was dropped fixed in 4%PFA for 24hr and then cleared with 1% SDS while the 
right side was dropped fixed in 4%PFA for 24hr, fixed in 3µl of 10% GA for 24hr, and then cleared 
with 6% SDS.. The four middle images are maximum intensity projections of single cortical tiles 
from each brain section half. The lower 25x image shows no overlap between PV and SST 
populations in non-GA treated brain. B, Same as A but brain section is stained with Rat anti-SST 
YC7. The left side of the SST stained brain was dropped fixed in 4%PFA for 24hr, fixed in 3µl of 
10% GA for 24hr, and then cleared with 6% SDS while the right side was dropped fixed in 4%PFA 
for 24hr and then cleared with 1% SDS. The lower 25x image shows overlap between transgenic 
SST and IHC labelled SST in non-GA treated brain. 
 
Double staining with PV and SST antibodies 
It is important to be able to stain for multiple GABAergic subtypes in the same tissue since this 
molecular characterization will allow for future experiments to interpret relative activity of 
subtypes during behavior. Thus, tissue was prepared in such a way to allow for both SST and PV 
staining to show that staining for at least two GABAergic subtypes simultaneously in thick tissue 
is possible. Mouse anti-SST H-11 and Rabbit anti-PV were used to double stain in one cuboid 
while Rat anti-SST YC7 and Rabbit anti-PV were used to double stain in another cuboid. VIP was 
not used since it was also raised in Rabbit and this would cause both PV and VIP neurons to be 
stained indiscriminately.  Cuboids were drop fixed for 24 hours in 4%PFA and then delipidated in 
SDS and then stained with both antibodies simultaneously. Figure 12 shows the successful double 
staining with SST neurons labelled in magenta and PV neurons labelled in green. It is evident that 
there are more PV neurons stained than SST neurons in both cuboids. This finding is consistent 
with the cell counting results in Figure 9 showing that there are more PV neurons than SST neurons 
in the mouse PFC. The lack of overlap between the two GABAergic subpopulations is evident in 
Figure 12 in the 25x imaging which is consistent with transgenic versus IHC results from the 
Figure 11 in which PV staining did not overlap with transgenic expression of SST. One observation 
that was noted with SST antibodies is that the fibrous tracts in the striatum appear to stain quite 
intensely as noted in the upper right image of Figure 10.  
 
Figure 12 – Successful double labelling with SST and PV in mouse PFC | Images showing 
successful double staining with Mouse anti-SST H-11 and Rabbit anti-PV and also with Rat anti-
SST YC7 and Rabbit anti-PV. Cuboids were fixed in 4%PFA for 24 hours and then treated with 
2% SDS for 2 days and then stained with the respective antibodies. Smaller 25x images show lack 
of overlap between populations of SST and VIP. Bottom images show the maximum intensity 
projections of a single tile with both individual channels depicted side by side to show staining in 
both channels. 
 
Primary Omissions 
Primary omissions were conducted for each secondary antibody used in the final results to show 
the background signal and autofluorescence of the tissue without primary antibody labelling. Low 
background was observed showing that specific staining was due to primary antibody interactions. 
It is evident that with the Gt a-MsIgG1 the striatum appears stained with secondary. This was 
observed in a few samples using this secondary thus this pattern was determined to not be due to 
specific staining of SST. 
 
Figure 13 – Primary Omissions | Images showing background signal and tissue autofluorescence 
of four secondary antibodies used in SST, PV, and VIP immunostaining.  
 
 
 
 
 
Antibody testing 
The following charts summarize the GABA interneuron antibodies that were tested. Antibodies 
were selected based on literature showing successful staining results in thin tissue.  
 
Primary Antibody Host Clonality Amount and Concentration 
Dilution 
Factor Company 
Catalogue 
Number 
Staining in 
thick tissue 
Rating 
in thick 
tissue 
(1-5) 
anti-Somatostatin Chicken polyclonal 5ul of unavailable concentration 1:200 SYSY 366 006 no - 
anti-Somatostatin Rat polyclonal 5uL of 1mg/ml 1:200 Millipore MAB354 no - 
anti-Somatostatin  (H-
11) mouse monoclonal 7.5uL of 0.2mg/ml 3:400 
Santa Cruz 
Biotechnology 
Inc. 
sc-74556 yes 5 
anti-Somatostatin  
(YC7) Rat monoclonal 7.5uL of 0.2mg/ml 3:400 
Santa Cruz 
Biotechnology 
Inc. 
sc-47706 yes 5 
anti-Somatostatin  (D-
12) Mouse monoclonal 7.5uL of 0.2mg/ml 3:400 
Santa Cruz 
Biotechnology 
Inc 
sc-25262 yes 3 
anti-Somatostatin  (G-
10) Mouse monoclonal 7.5uL of 0.2mg/ml 3:400 
Santa Cruz 
Biotechnology 
Inc. 
sc-55565 no - 
anti-Parvalbumin Goat polyclonal 5uL of 0.5mg/mL 1:200 Abcam ab32895 yes 3 
anti-Parvalbumin Rabbit polyclonal 5uL of 0.5mg/mL 1:200 GenScript A01439-40 yes 5 
anti-Parvalbumin Rabbit polyclonal 7.5uL of 1ug/uL 1:200 Bioss bs-1299R no - 
anti-Vasoactive 
Intestinal Peptide Rabbit polyclonal 
7.5uL unavailable 
concentration 1:200 ImmunoStar 20077 yes 3 
anti-Vasoactive 
Intestinal Peptide (H-
6) 
Mouse monoclonal 7.5uL of 0.2mg/ml 3:400 
Santa Cruz 
Biotechnology 
Inc. 
sc-25347 no - 
Table 1. Primary antibodies tested against SST, PV, and VIP. Antibodies were used to stain cortical mouse GABA interneurons in 
2mm thick tissue. The rating reflects the overall ability of the antibody to stain thick tissue in addition to the number of cells stained 
and intensity of cell body staining. 
 
 
Secondary 
Antibody Host 
Conjugated 
Fluorophore/Dye Concentration 
Dilution 
Factor Company 
Catalogue 
Number 
anti-Chicken IgY 
(H+L) Goat Alexa Fluor 647 10uL of 1mg/ml 1:200 Invitrogen A-21449 
anti-Rat IgG 
(H+L) Donkey Alexa Fluor 647 12uL of 1mg/mL 1:200 Invitrogen A-31573 
anti-Mouse IgG1 Goat Alexa Fluor 647 12uL of 0.5mg/ml 3:400 Invitrogen A21120 
anti-Mouse 
IgG2b Goat Alexa Fluor 647 12uL of 0.5mg/ml 3:400 Invitrogen A21140 
anti-Mouse 
IgG2a Goat Alex Fluor 647 12uL of 0.5mg/ml 3:400 Invitrogen A21130 
anti-Goat IgG 
(H+L) Donkey Alexa Fluor 633 10uL of 1mg/mL 1:200 Invitrogen A21447 
anti-Rabbit IgG 
(H+L) Donkey Alexa Fluor 647 10uL of 1mg/ml 1:200 Invitrogen A31573 
Table 2. List of all secondary antibodies tested. Concentration and volume of SST secondary antibodies was determined by 
multiplying successful volumes from thin tissue by a factor accounting for volume and surface area of a cuboid compared to a thin 
section. 
 
Discussion 
GABA interneurons in the PFC are integral to proper higher-order brain functions such as decision 
making and motivation. Understanding how GABA interneurons function at homeostasis to 
regulate normal behavior will provide insight into how dysregulation could lead to mental illness 
or other neural problems. Molecularly characterizing different subtypes of GABA neurons and 
understanding their different functions through calcium imaging has been pursued by few in the 
field of neuroscience. Those who have attempted this characterization have done so in thin tissue 
sections. By optimizing methods to stain for the three major GABA neuron subtypes, SST, PV, 
and VIP, in thick tissue, this study provides the tools for future studies to molecularly characterize 
GABA neuron subtypes in thick tissue after recording their activity during behavior.  
 
Initial failure to stain for both SST and VIP in thick tissue prompted testing of failed antibodies in 
thin tissue using traditional thin slice techniques. Preparing thick tissue in the exact same way as 
thin tissue (24 hour 4%PFA drop fix, no GA, no SDS) produced successful staining. After 
successful staining using traditional thin tissue techniques, the search began for the factors that 
were inhibiting staining in thick tissue.  
 
Experiments showed that over-fixation with PFA was a main factor preventing staining. Cuboids 
fixed for 5 days in 4%PFA and then subsequently fixed in GA were used initially since this is a 
typical fixation duration to allow for tissue structure preservation during 6% SDS delipidation at 
37°C. Since in all cases GA caused very high background compared to signal, it should not be 
used routinely and other fixatives should be tested in replacement. Fixation for just 24 hours in 
4%PFA allowed for staining of both SST and VIP neurons.  Thus for the purposes of staining 
GABA interneurons, this duration of fixation can be chosen and staining will be possible. In future 
experiments, it might be beneficial to test the effects of 48 hour and 72 hour 4%PFA fixation on 
SST and VIP staining since increased fixation without detriment to IHC will help to maintain tissue 
integrity during clearing. It is possible that 48 hours of 4%PFA drop fix might still be compatible 
with SST and VIP staining but this needs to be tested under controlled conditions. Thick tissue 
IHC protocols often drop fix tissue in 4%PFA for between 20 hours and 3 days or use PFA/GA 
combinations to both preserve tissue and allow for antibody staining15,17,34.  
 
GA was also found to play a large role in the inhibition of thick tissue staining. As mentioned 
above, fixation is important to maintain shape and structure of tissue, especially in thick tissue to 
prevent distortion due to SDS delipidation. GA is an especially useful fixative since it is both 
strong and fast and thus helps maintain transgenic protein fluorescence and overall tissue integrity. 
Unfortunately, GA fixation often has negative impacts on IHC. It is known that GA fixation can 
impact the epitope of interest due to excessive cross-linking. Cross-links can mask epitopes and 
even change the quaternary and tertiary structure of the epitope that the antibody is meant to 
recognize19,25. Exact reactions to show how GA reacts with amine groups in tissue to change 
protein structure are not understood which makes it hard to know how the GA will impact the 
epitope of interest and how this will impact detection of an epitope through IHC25, 32, 33.  
 
Since it is hard to predict how GA will affect an epitope and thus IHC, it was interesting to see 
how differently GA affected SST and VIP staining versus PV staining. Staining a heavily GA-
fixed cuboid with Mouse anti-SST H-11 did not produce any visible cell body staining. Further 
staining of this same cuboid with Rabbit anti-PV produced a relatively high level of cell body 
staining showing that GA must not be masking or destroying PV epitopes but is certainly impacting 
SST epitopes in some way. Since the experiment was done within the same cuboid it isolated many 
confounds such that differences in staining could be attributed to GA’s effects on antibody/antigen 
interactions. 
 
One possible hypothesis to explain these results might be that high abundance of an antigen 
increases the probability of interaction between antibody and antigen in the presence of impeding 
cross-links. PV is known to be an abundant cytosolic calcium binding protein that can diffuse 
throughout the neuron to exhibit its calcium binding and moderating capacities35,33. SST is a 
neuropeptide that is stored in vesicles and released mainly from axon terminals to modulate 
activity of other neurons36. The pro form of SST, called pro-somatostatin, is made in the nucleus 
and is then transported down the axons to the terminals in small synaptic vesicles prior to release36. 
Interestingly, SST has been found to localize inside large dense-core vesicles in the soma, axon, 
and dendrites waiting to be released from these locations33. Overall, PV appears to be abundant 
and more diffuse than SST which might increase the chances of PV antibody-antigen interactions 
despite numerous GA induced cross-links that mask epitopes and block antibodies from accessing 
antigens37,38. 
 
Another explanation of the difference in SST and PV staining with GA could be differences in 
subcellular antigen location. Fixatives have been shown to have differing impacts on the ability of 
molecules to stain depending on cellular location. Webster et al.39 found that antigens in the 
cytoplasm decrease in immunoreactivity the longer they are fixed when compared to antigens 
found in the cell membrane, nucleus, or extracellularly.  Webster et al.39 did not study vesicular 
proteins thus this finding might be an interesting addition to their data with further research. 
Although future research must be done to support this idea, I hypothesize that molecules in vesicles 
may experience increased steric hindrance and thus have epitopes that are harder to reach. Tight 
packing in SST vesicles might increase steric hindrance and decrease the opportunities for correct 
antibody-epitope interactions. Since fixation can cause epitopes to be masked by extensive cross-
linking which also creates steric hindrance, this effect might be enhanced for molecules that are 
present in vesicles37,38.  
 
To further understand how and why epitopes are affected differently by different fixatives would 
require an in-depth analysis of fixation chemistry and cellular localization. For now, antigen 
retrieval experiments40,41 should be pursued with the SST and VIP antibodies that did not initially 
work in thick tissue to see if this process might unmask hidden epitopes and thus allow for antibody 
binding29. In addition, perfusion with 2% PFA has been shown by Mo et al.42 to visualize specific 
VIP staining while perfusion with 4%PFA inhibited staining. In addition to trying lower fixative 
concentrations, less conventional fixatives like glyoxal should be tested to see if epitopes maintain 
immunogenicity better than when treated with GA. Glyoxal has been shown to have good fixative 
properties while not masking or denaturing epitopes as GA does43. Glyoxal has allowed for 
successful staining of proteins in many cellular locations such as cytoplasm, membrane, vesicular, 
mitochondrial, endoplasmic reticular, and Golgi apparatus43. Lastly, immunostaining with 
antibodies raised against GA treated antigens has been shown to allow for staining after GA 
fixation38,37. This would be an interesting path to pursue since GA might be necessary to preserve 
tissue well enough that cell alignment between in vivo imaging and ex vivo immunostaining is 
possible with minimal worry of SDS mediated tissue distortion. 
 
While fixation appeared to be a major reason for lack of staining, blocking, which was initially 
hypothesized to have major effects on tissue staining, was shown to be unnecessary. Blocking is 
commonly used in thin tissue staining as a means to prevent non-specific interactions between 
antibodies and Fc receptors or other molecules in tissue samples30. In addition to prevention of 
non-specific interactions with the tissue itself, blocking is thought to prevent interactions between 
antibody and the container in which tissue is being incubated. Prevention of non-specific 
interactions decreases background signal and thus enhances signal to noise ratio of staining29,30. 
For these reasons, it makes sense to block tissue and thus blocking has been a mainstay throughout 
the history of IHC.  
 
In newer thick tissue staining protocols, blocking appears to be less important since staining in 
conjunction with CLARITY often does not include blocking15,17,26 suggesting that it is 
unnecessary. Since blocking was one of the main differences between thin tissue preparation and 
thick tissue preparation, I was interested in seeing if lack of staining or decreased effectiveness of 
staining in thick tissue was due to lack of blocking. There was no difference in average signal 
between blocked and non-blocked samples for both Rab anti-PV and Mouse anti-SST H-11. These 
results agree with recent findings that blocking may not be necessary29,30,41. In the future, 
anatomically matched cuboids should be used to replicate this finding as this would enable a fairer 
fluorescence comparison and also enable a fairer comparison for cell counting. It seemed in both 
graphs in Figure 8 that blocked tissue had a higher level of fluorescence at the surface of the tissue. 
This finding may be confounded by anatomical differences between blocked and non-blocked 
cuboids, so this experiment should be replicated in anatomically matching cuboids. Although 
blocking did not appear to make a difference in overall fluorescence intensity, it would be 
interesting to see if a significantly larger number of cells are stained when blocking is used. All 
future replications of this experiment should be done with enough replicates to allow for 
significance testing since time and tissue constraints in this study did not allow for enough 
replicates to test for statistical significance of this finding. 
 
Effects of SDS on Antibody Staining 
SDS delipidation will effectively clear thick tissue of lipids preventing scattering of light as it 
passes through tissues. Since SDS is one of the many factors that differs between thin and thick 
tissue preparation, I was interested in seeing if SDS delipidation prior to staining tissue might be 
inhibiting staining. Depilidation after staining did not prove to be effective. Although tissue had 
less background signal, there was also less antibody staining showing that SDS removes antibody 
staining. 
 
In previous research, SDS has been shown to elute antibodies at both high temperature17 and low 
pH28 but not at neutral pH and average body temperature of 37°C. Initially, reduced staining was 
thought to be due to the denaturing of fluorophores conjugated to secondary antibodies. Thus I 
hypothesized that addition of another round of secondary antibody might re-stain existing primary 
antibodies and bring back the signal. Since the number of detectable cells decreased after re-
staining with secondary antibodies, it was determined that denaturing of secondary antibody 
fluorophores was not the main reason for decreased staining after SDS treatment. In the future, 
SDS-treated tissue should be re-stained with primary antibody to determine if primary antibody 
removal was the source of lost signal. If further treatment of these same tissues with primary 
antibody led to revival of staining signal, primary antibody removal at neutral pH and moderate 
temperature is probably causing the decrease in signal. If addition of primary does not produce 
more cell body staining, then the epitopes are possibly being denatured by SDS. It would be 
valuable to pursue future experiments to determine if the cause of lost signal is due to elution of 
primary antibody at neutral pH and average temperature since current methods to elute antibody 
are more aggressive to tissue and decrease tissue integrity and structure after multiple staining 
rounds17. Overall, this experiment showed that using SDS after staining is not an effective method 
to both stain and clear tissue. 
 
GABA Interneuron Populations 
After looking at the many factors that impact thick tissue staining, I looked at the accuracy of 
GABA interneuron staining by comparing my findings to others who have stained for SST, PV, 
and VIP. Of the major GABA interneuron subtypes, PV appears to be the most abundant in the 
cortex with SST second most abundant, and VIP third most abundant 12,13,31,33. These previous 
findings agree with the cell counting results in Figure 9 since PV appeared to be the most abundant 
GABA interneuron subtype and VIP appeared to be the least abundant.  
 
The way that neurons stained differed between subtypes. Initially, the SST and VIP staining was 
thought to be non-specific, staining mostly the background or neuropil. Cell bodies were not 
clearly filled as they were when staining with PV antibodies. Further research showed that this 
pattern of staining SST, PV, and VIP subtypes in neural tissue has been noted multiple 
times6,31,33,44. SST neurons stain better around the cell periphery, often producing hollow cell 
bodies with absent dendritic staining21,35. PV neurons have fully stained cell bodies, and VIP 
neurons appear thin and granular when stained and often have lots of stained fibers in the 
background6,31,33,44. VIP neurons in particular have staining that at first appears to be nonspecific 
due to the staining of wide arrays of slender axonal trees and dendrites running perpendicular to 
each cortical layer44.  
 
Transgenic Lines Support IHC Results 
SST-Cre mouse lines were used to test for co-localization of SST staining with TdTom expressing 
SST neurons while PV-Cre mouse lines were used to test for co-localization of PV stain with 
TdTom expressing PV neurons. Overlap between transgenic and IHC stained populations of the 
same subtype was expected but no overlap was expected between transgenic and IHC stained 
populations of different GABAergic subtypes since research has shown that these SST and PV 
populations are distinct in the mouse PFC31,45. I did observe overlap between the IHC stained SST 
cells and the transgenically labelled SST cells in the SST-Cre line. I did not observe any overlap 
between antibody stained PV and transgenically labelled SST in the SST-Cre line. These results 
helped confirm that both the SST and PV staining worked as expected. Future research should 
focus on replication of this finding to confirm that IHC staining matches transgenic expression in 
most cases. 
 
I expected the PV-Cre line to work since it has been shown to work by others using the same 
Pvalb-Cre mice from Jax that I used46. Unfortunately, the line failed to specifically label PV 
neurons leading to global expression of TdTom throughout the brain. These samples therefore 
could not be used in this project to determine efficiency of overlap between IHC stained PV 
neurons and transgenically labelled PV neurons. In the future, a working PV-Cre line should be 
obtained in order to look at the overlap between IHC stained PV neurons and transgenically 
labelled PV neurons.  
 
Double Staining for PV and SST 
Successful double staining with SST and PV was achieved in 4%PFA fixed cuboids. The lack of 
overlap in PV and SST populations is supported by others in the field as these populations appear 
to be independent in the mouse cortex5,31,32.  The way in which SST and PV neurons stain differs 
as described in the transgenic versus immunohistochemical labelling experiment. SST cells appear 
to stain around the exterior and do not fill in cell bodies, and this result is consistent in all 
immunohistochemical staining of SST in this study and others6,7,31. PV staining appears to fill in 
cell bodies and have less fibrous staining which is consistent throughout this experiment and 
others6,31. In the future, a VIP antibody that is not raised in Rabbit should be optimized in thick 
tissue such that simultaneous triple labelling can be done in thick tissue.  
Concluding Remarks 
Variable Experimental Observation Conclusion for Future 
Staining 
PFA Shorter drop fix led to better 
staining 
4%PFA drop fix for 24 hours 
is sufficient to allow specific 
SST, PV, and VIP staining 
GA Led to high background 
fluorescence in all samples. 
Led to undetectable staining 
with SST and VIP 
If possible refrain from using 
GA when staining for SST 
and VIP. GA is compatible 
with PV staining 
SDS SDS treatment after staining 
decreased signal drastically. 
SDS did not appear to have a 
huge impact on antibody 
penetration 
SDS should not be used to 
clear tissue after staining 
since signal will diminish 
Blocking Did not appear to decrease 
non-specific staining  
Blocking is not necessary in 
thick tissue protocols with 
SST, PV, and VIP 
Table 3 | Overview of variables tested, results obtained, and suggestions for future staining. 
Overall, this study demonstrated that the three major GABAergic neural subtypes, SST, PV, and 
VIP, can be stained for in thick tissue via optimized immunohistochemical techniques. However, 
there are limitations to this study. I tried to focus on testing a broad range of factors rather than 
focusing on one factor and creating many replicates to enhance statistically significance of data. 
One way more replicates could have been included in this study, with limited time and tissue, is 
by imaging all six sides of each cuboid to generate larger and fuller data sets for each cuboid. 
Imaging all six sides by rotating the tissue cuboid in the mounting chamber would increase the 
number of replicates and enable statistical testing with the data. The “Cuboid Method” sets up the 
platform for high throughput studies of factors affecting thick tissue immunostaining such that one 
factor can be tested in many cuboids at one time. The broad testing in this study was informative 
enough to allow for initial tests at molecularly identifying GABAergic subtypes that were recorded 
through in vivo calcium imaging. If future research using the cuboid method focuses on large scale 
replicate studies of the factors tested in this study, it will enable others with the knowledge to 
molecularly label a much broader range of neurons in thick tissue. 
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